Merck boosts heart disease research

2008-11-12 메디칼라이터팀

Merck & Co. has eight heart drugs in human testing, almost a fifth of all its late-stage projects. The company is experimenting with drugs to reduce blood vessel inflammation, blood pressure medicines with fewer side effects and treatment to increase so-called good cholesterol. The company wants to buy or collaborate with companies with promising cardiac treatments.